CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES ›› 2024, Vol. 42 ›› Issue (6): 783-789.doi: 10.12140/j.issn.1000-7423.2024.06.014

• REVIEWS • Previous Articles     Next Articles

Advances in surgical treatment of hepatic alveolar echinococcosis

ZULIPIKAER Tusunniyazi(), JIANG Tiemin, WEN Hao*()   

  1. The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang, China
  • Received:2024-04-12 Revised:2024-08-28 Online:2024-12-30 Published:2025-01-14
  • Contact: E-mail: dr.wenhao@163.com
  • Supported by:
    Xinjiang Uygur Autonomous Region Key Laboratory Opening Topic Fund(2021D04024)

Abstract:

Hepatic alveolar echinococcosis (HAE) is a zoonotic disease. It is predominantly found in regions such as Xinjiang, Qinghai, Xizang and Sichuan in China. HAE can cause severe and irreversible damage, and significantly impacting human health and regional economies. The prevention and control of HAE remains a key focus of national disease prevention and control efforts. Radical surgical resection is the preferred treatment for HAE; while palliative surgery and liver transplantation are alternative options for late-stage HAE cases radical resection is not suitable. This article provides an overview of the current treatment status and latest advancements in the management of HAE.

Key words: Hepatic alveolar echinococcosis, Surgical treatment, Advances in treatment

CLC Number: